Skip to research content
Public research library
Topic CEIL

Benchmark ceiling and cheapest lawful option

Published findings, original references and room for an evidence-backed challenge.

What the rubric looks for

Plan claim cost can never exceed a published benchmark, for example the transparent cash price at a benchmark site, in any channel and for any drug, and the ceiling is checked claim by claim rather than on average.

Why it matters

A ceiling protects the plan from paying more through the contract than the public can pay in cash, and a claim level test stops a favorable average from hiding individual overcharges.

CEIL · Weight 3/100 · Introduced in rubric v1

Reference: Section 3.3

Only the selected record is loaded. Findings below are not a cross-contract tally or community activity.

Published evidence

Travis County · Envision Pharmaceutical Services, LLC

Published Commons finding

Not addressedFinding rubric version not recorded

No evidence quotation was recorded for this finding.

Recorded reference: No page reference recorded

Published rationale. All five models reached this verdict. The pricing summary on pages 10 and 11 sets discounts off average wholesale price but never caps what the plan pays against a published benchmark or a cash price, and there is no claim by claim test. The subject does not appear in the memoranda or the consultant notes on page 17. The executed agreement is not part of this agenda backup and nothing in the 18 pages is redacted, so the subject is absent rather than unreadable.

“Not addressed” is this published review’s conclusion about the produced text, not proof that a provision is absent from every version or withheld document.

Inspect historical council readings (5 recorded for this criterion)

These are separately attributed readings of this record, not independent community contributions. Versions can differ; no new consensus has been calculated.

Claude Opus 5

Not addressedRubric v2 · Historical council reading

No evidence quotation was recorded for this finding.

Recorded reference: No page reference recorded

Published rationale. The pricing summary on pages 10 and 11 sets discount rates off average wholesale price but never caps what the plan pays against any external published benchmark such as a transparent cash price. There is no claim by claim test and no statement that the county will never pay more than a publicly available price. The subject does not appear in the memoranda, the consultant notes on page 17 or anywhere else in the packet.

“Not addressed” is this published review’s conclusion about the produced text, not proof that a provision is absent from every version or withheld document.

Gemini 3.1 Pro

Not addressedRubric v2 · Historical council reading

No evidence quotation was recorded for this finding.

Recorded reference: No page reference recorded

Published rationale. The agenda backup does not contain the executed agreement and does not address benchmark ceilings or cheapest lawful option pricing.

“Not addressed” is this published review’s conclusion about the produced text, not proof that a provision is absent from every version or withheld document.

GPT 5.6 Sol

Not addressedRubric v2 · Historical council reading

No evidence quotation was recorded for this finding.

Recorded reference: No page reference recorded

Published rationale. The pricing tables on pages 10 and 11 use AWP discounts and dispensing fees. They do not cap each claim at a published cash benchmark or the cheapest lawful option, and no claim-level ceiling appears elsewhere in the packet. The executed agreement that might contain such a ceiling is not included.

“Not addressed” is this published review’s conclusion about the produced text, not proof that a provision is absent from every version or withheld document.

Grok 4.6

Not addressedRubric v2 · Historical council reading

No evidence quotation was recorded for this finding.

Recorded reference: No page reference recorded

Published rationale. The rate tables on pages 10 and 11 are AWP discounts and dispensing fees. There is no claim-by-claim ceiling against a published cash price or other public benchmark. Pages 1 through 18 do not mention a cheapest lawful option test.

“Not addressed” is this published review’s conclusion about the produced text, not proof that a provision is absent from every version or withheld document.

Kimi K3

Not addressedRubric v2 · Historical council reading

No evidence quotation was recorded for this finding.

Recorded reference: No page reference recorded

Published rationale. No page sets a claim-level ceiling tied to a published benchmark or cash price. The rate tables on pages 10 and 11 are AWP discount guarantees only. A benchmark ceiling is not mentioned anywhere in the 18 pages.

“Not addressed” is this published review’s conclusion about the produced text, not proof that a provision is absent from every version or withheld document.

Document manifest and citation limits

Quotations and rationales are reproduced from published findings, not newly verified here. Named exhibits, amendments and ambiguous references must be checked in the document itself.

Community participation

Have contrary evidence, a missing exhibit or a question about the interpretation? Use the existing community composer to prepare a labelled finding. Publishing a community post is separate from a Commons review and does not change the contract score.

This research topic is not a membership channel. Following topics and private agency workspaces are not enabled here.

PBM Commons · by BetterBuy RxEvidence is public. Interpretation is open to review.

Commons navigation

Find a public record